Document is current
Any future updates will be listed below
-
Authors
Guo, Wangxin https://orcid.org/0000-0002-8578-6035
Zhang, Xiaoyu
Li, Lin https://orcid.org/0000-0002-3558-323X
Shao, Pengfei
Liang, Chao
Zhang, Hongjiong
Liu, Kuo
Wang, Shuoming
Peng, Yunyi
Luo, Jun https://orcid.org/0000-0002-1414-473X
Ju, Yi
De Marzo, Angelo M. https://orcid.org/0000-0003-4847-5307
Yu, Chen https://orcid.org/0000-0003-3232-3931
Chen, Luonan https://orcid.org/0000-0002-3960-0068
Zhou, Bin https://orcid.org/0000-0001-5278-5522
Gao, Dong https://orcid.org/0000-0003-1821-2741
- License Information
-
More Information
Article History
Received: 25 June 2023
Accepted: 9 October 2024
First Online: 13 November 2024
Competing interests
: D.G., W.G., X.Z. and H.Z. have filed a patent application regarding targeting JAK/STAT signaling for prostatitis and prostate hyperplasia treatment. The other authors declare no competing interests.
